On the battery life of a totally implantable active middle ear device: a retrospective study in a single implanting center.

Active middle ear device audiometry battery change surgery battery life bone conduction threshold esteem system totally implantable system

Journal

Acta oto-laryngologica
ISSN: 1651-2251
Titre abrégé: Acta Otolaryngol
Pays: England
ID NLM: 0370354

Informations de publication

Date de publication:
Jan 2023
Historique:
pubmed: 4 1 2023
medline: 9 2 2023
entrez: 3 1 2023
Statut: ppublish

Résumé

Totally-implantable active middle ear devices (AMED) rely on a non-rechargeable battery encased with the implantable sound processor that needs to be replaced with a minor surgical procedure after its depletion. This study aimed to investigate the most significant factors affecting the implant's battery life. The implanted subjects (29 patients) were divided into three groups; group A with 17 patients who underwent one battery change surgery; group B with ten patients who underwent two battery changes; and group C with two patients and three surgeries. The battery life was put in correlation with several variables, including daily use and the auditory threshold. The battery life ranged from 26 to 67 months, with a mean of 48.93 ± 13.47. Pearson's correlation coefficient revealed that the battery life was statistically correlated only with the mean post-implantation bone conduction thresholds ( Although the non-rechargeable battery system of the AMED under study overcomes the drawbacks of daily charging, it needs to be surgically changed after its depletion. The different rates of battery life were shown to mainly depend on the post-implantation BC thresholds, which in some cases showed a deterioration concerning the pre-implanting values.

Sections du résumé

BACKGROUND UNASSIGNED
Totally-implantable active middle ear devices (AMED) rely on a non-rechargeable battery encased with the implantable sound processor that needs to be replaced with a minor surgical procedure after its depletion.
OBJECTIVES UNASSIGNED
This study aimed to investigate the most significant factors affecting the implant's battery life.
MATERIALS AND METHODS UNASSIGNED
The implanted subjects (29 patients) were divided into three groups; group A with 17 patients who underwent one battery change surgery; group B with ten patients who underwent two battery changes; and group C with two patients and three surgeries. The battery life was put in correlation with several variables, including daily use and the auditory threshold.
RESULTS UNASSIGNED
The battery life ranged from 26 to 67 months, with a mean of 48.93 ± 13.47. Pearson's correlation coefficient revealed that the battery life was statistically correlated only with the mean post-implantation bone conduction thresholds (
CONCLUSIONS UNASSIGNED
Although the non-rechargeable battery system of the AMED under study overcomes the drawbacks of daily charging, it needs to be surgically changed after its depletion. The different rates of battery life were shown to mainly depend on the post-implantation BC thresholds, which in some cases showed a deterioration concerning the pre-implanting values.

Identifiants

pubmed: 36594700
doi: 10.1080/00016489.2022.2161625
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6-11

Auteurs

Maurizio Barbara (M)

Department of Neuroscience, Mental Health, and Sensory Organs, Sant Andrea University Hospital, Sapienza University, Rome, Italy.

Valerio Margani (V)

Department of Neuroscience, Mental Health, and Sensory Organs, Sant Andrea University Hospital, Sapienza University, Rome, Italy.

Luigi Volpini (L)

Otorhinolaryngology Department, Liverpool University Hospitals NHS Foundation Trust, UK.

Chiara Filippi (C)

Department of Neuroscience, Mental Health, and Sensory Organs, Sant Andrea University Hospital, Sapienza University, Rome, Italy.

Edoardo Covelli (E)

Department of Neuroscience, Mental Health, and Sensory Organs, Sant Andrea University Hospital, Sapienza University, Rome, Italy.

Simonetta Monini (S)

Department of Neuroscience, Mental Health, and Sensory Organs, Sant Andrea University Hospital, Sapienza University, Rome, Italy.

Haitham H Elfarargy (HH)

Otorhinolaryngology Department, Kafrelsheikh University, Kafrelsheikh, Egypt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH